Phase I pharmacokinetic trial of tivantinib: Absorption, distribution, metabolism, and excretion of 14C-labelled tivantinib in healthy male volunteers.

Trial Profile

Phase I pharmacokinetic trial of tivantinib: Absorption, distribution, metabolism, and excretion of 14C-labelled tivantinib in healthy male volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Mar 2012

At a glance

  • Drugs Tivantinib (Primary)
  • Indications Cancer
  • Focus Pharmacokinetics
  • Sponsors ArQule; Daiichi Sankyo Inc; Kyowa Hakko Kirin
  • Most Recent Events

    • 31 Mar 2012 New trial record
    • 29 Mar 2012 Results will be presented at AACR-2012 according to an ArQule media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top